What to do if you are resistant to Riluzole

Riluzole (Riluzole, a drug that prolongs the survival of amyotrophic lateral sclerosis (ALS) patients, reduced mortality by 35% at a dose of 100 mg in a clinical trial. Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease of upper and lower motor neurons that can lead to progressive paralysis and ultimately death from respiratory failure.

Riluzole (100 mg/day) was associated with longer survival in the final clinical stage of ALS before death (stage 4) compared with placebo, and there were no differences in the time from stage 2 or stage 3 to subsequent stages or death between the riluzole and placebo groups. These findings suggest that the disease-modifying effects and survival benefits of riluzole occur later in the disease. If the disease cannot be controlled by riluzole or is very resistant, doctors may consider other treatment options, which may include new drugs, neuroprotective agents, gene therapy, or participation in clinical trials.

The original drug Riluzole has been launched in China and has entered the scope of Class B medical insurance. Specifications The price of 50mg*56 tablets per box may be around 4,000 RMB. The price of the Turkish version of Riluzole’s original drug, 50mg*56 tablets, sold overseas may be around RMB 1,200 per box (the price may fluctuate due to exchange rates). There are also generic drugs produced in other countries. The price of a box of 50mg*30 tablets produced by an Indian pharmaceutical factory may be around RMB 1,300 (the price may fluctuate due to the exchange rate). The pharmaceutical ingredients of generic drugs are basically the same as those of domestic and foreign original drugs. For specific prices and drug information, please consult Yaode Medical Consultants.